As shown in Fig. 3B–D, we found that the expression of LPCAT1 increased statistically with the increase of clinical stage and grade of HCC patients (Grade: G1 vs G2, p = 7.6e−03; G1 vs G3, p = 1.6e−06; G1 vs G4, p = 4.8e−03; G2 vs G3, p = 7.7e−04; Stage: StageI vs Stage II, p = 2.7e−04; StageI vs Stage III, p = 3.7e−06; T: T1 vs T2, p = 9.2e−05; T1 vs T3, p = 4.9e−05). Here, LPCAT1 is linked to hepatocellular carcinoma.